An Integrative approach in the management of Uncontrolled type 2 Diabetes Mellitus w.s.r. to Sthula Madhumeha: A Case Report
Abstract
Introduction: Diabetes is a disease of worldwide importance and a major public healthcare concern owing to its associated morbidity. Clinically Type 2 DM resembles Madhumeha with prevalence in India was 9.6% in 2021.This case report describes an integrated approach for the treatment of uncontrolled diabetes mellitus. Main clinical Findings: A 58-year-old male patient complained of polyurea, polyphagia, polydipsia, tingling, and severe burning in all 4 limbs, fatigue, and constipation. Investigations shows FBSL level of 247mg/dl, PPBSL 415mg/dl, and HbA1C 8.9%, BMI 28.6kg /m2. Diagnosis: Sthula-Madhumeha (Type 2 Diabetes Mellitus). Interventions: Treatment includes, Panchatiktapanchaprasutika Basti for consecutive 15 days (Kalbasti Krama), local therapy, oral medications and lifestyle modifications. Outcome: Patient showed marked reduction in FBSL reduced to 82mg/dl PPBSL to 184mg/dl, and HbA1c to 6.8% after 3 months. Patient exhibited significant results in clinical signs and symptoms. Conclusions: It can be concluded that Ayurvedic intervention can be a complimentary treatment in uncontrolled DM.
Downloads
References
World Health Organisation. Diabetes Overview [Internet]. 2023 [cited 2024 Feb 5]. Available from: https://www.who.int/news-room/fact-sheets/detail/diabetes
Kumar A, Gangwar R, Zargar AZ, Kumar R, Sharma A. Prevalence of diabetes in India: a review of IDF Diabetes Atlas 10th Edition. Curr Diabetes Rev. 2024;20(1):105-14. doi: 10.2174/1573399819666230413094200.
Li M, Chi X, Wang Y, et al. Trends in insulin resistance: insights into mechanisms and therapeutic strategy. Signal Transduct Target Ther. 2022;7(216). doi: 10.1038/s41392-022-01073-0.
Hollander P. Anti-diabetes and anti-obesity medications: effects on weight in people with diabetes. Diabetes Spectr. 2007;20(3):159-65. doi: 10.2337/diaspect.20.3.159.
Sharma AR. Sushrut Samhita. Varanasi: Chaukhambha Pratishthan; 2017. Nidansthana, Adhyay 6/4.
Kale VS. Charak Samhita. Chaukhambha Sanskrit Pratishthan; 2013. Sutrasthan, Adhyay 21/21-23. p. 117.
Jirankalgikar YM, Ashok BK, Dwivedi RR. A comparative evaluation of intestinal transit time of two dosage forms of Haritaki [Terminalia chebula Retz]. Ayu. 2012;33(3):447-9. doi: 10.4103/0974-8520.108866.
Geng J, Ni Q, Sun W, Li L, Feng X. The links between gut microbiota and obesity and obesity related diseases. Biomed Pharmacother. 2022;147:112678. doi: 10.1016/j.biopha.2022.112678.
Mangal A, et al. Evaluation of Gokshuradi Guggulu and Guduchi Churna in the management of Type II Diabetes Mellitus (Madhumeha). J Res Ayurvedic Sci. 2019. doi: 10.5005/jras-10064-0082.
Pandharkar G, Rasal P. Clinical efficacy of shodhanottara shamana chikitsa in type II diabetes mellitus – an exploratory study. Ayurlog. 2018;6(4):1-10.
Silva PASN, Arawwawala LDAM, Kumari MWSJ, Galappatthy P. Effect of Curcuma longa L. and curcumin on diabetes and its complications: a review. J Ayu Herb Med. 2021;7(2):109-18. doi: 10.31254/jahm.2021.7209.
Kumari S, SD L, B S, Khanal S. Efficacy of Integrated Ayurveda treatment protocol in Type 2 Diabetes Mellitus - A case report. J Ayurveda Integr Med. 2022;13(1):100512. doi: 10.1016/j.jaim.2021.08.005.
Gaidhani SN, et al. Antidiabetic activity of Vasant Kusumakar Ras in streptozotocin and high-fat diet induced Type 2 Diabetes Mellitus in Sprague Dawley rats. J Nat Remedies. 2023;23(2):521-36. doi: 10.18311/jnr/2023/32054.
Tamoli SM, et al. Vasant Kusmakar Ras, an ayurvedic herbo-mineral formulation prevents the development of diabetic retinopathy in rats. J Ayurveda Integr Med. 2020;11(3):270-6. doi: 10.1016/j.jaim.2020.02.002.
![](https://jaims.in/public/journals/1/article_4042_cover_en_US.jpg)
Copyright (c) 2025 Mohini Jamale, J.D. Gulhane, Mayur Gaikwad
![Creative Commons License](http://i.creativecommons.org/l/by-nc-sa/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Journal of Ayurveda and Integrated Medical Sciences (JAIMS) retains the copyright of the contents of this journal but grant the readers the right to use the contents with terms and conditions under a creative common attribution licenses 4 of Attribution, Share Alike and Non-commercial type (CC BY-NC-SA) that allows copy, distribute, display, and perform the work and make derivative works based on it only for non-commercial purposes.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.